In the latest episode of the People’s Pharmacy podcast on NPR, Foundation Chairman Neal F. Kassell, MD, discusses how focused ultrasound has transformed the treatment of movement disorders.
Also hear from a young-onset Parkinson’s patient whose life and career were changed by the technology.
Strong, bipartisan language on the importance of focused ultrasound and the patient experience was included in the US government’s 2026 funding appropriations bill.
The Foundation partnered with G2G Consulting to advocate for this legislation.
The Foundation is seeking opinions on a draft landscape analysis of AAV-based gene therapies for neurodegenerative diseases that could benefit from focused ultrasound.
“My family recognized that there was such a change in my emotional and social life [after focused ultrasound treatment]. For about six years, the depression took a toll on me and made me an introvert, and I am the ultimate extrovert.”